drugset / Trial / NCT02767817
Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury
Phase 1
Unknown
30 enrolled
Chinese Academy of Sciences
Affiliated Hospital of Logistics University of CAPF · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of injectable collagen scaffold combined with Mesenchymal stem cells (MSCs) transplantation in patients with brain injury.
Timeline
- Start
- 2016-03
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+07 cells | Other |